Joel Greenblatt's EW Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 33,456 shares of Edwards Lifesciences Corporation (EW) worth $2.6 M, representing 0.01% of the portfolio. First purchased in 2013-Q2, this long-term strategic position has been held for 50 quarters.
Based on 13F filings since 2013, Joel Greenblatt has maintained a long-term strategic position in EW, representing a significant commitment to this investment thesis. Largest addition occurred in Q2 2014, adding 1.12 M shares. Largest reduction occurred in Q2 2015, reducing 783,318 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Edwards Lifesciences Corporation (EW) Holding Value Over Time
Track share changes against reported price movement
Quarterly Edwards Lifesciences Corporation (EW) Trades by Joel Greenblatt
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2013 | +252,738 | Add 0.00% | 252,732 | $11.20 |
| Q3 2013 | -66,186 | Reduce 26.19% | 186,546 | $11.61 |
| Q4 2013 | +520,014 | Add 278.76% | 706,560 | $10.96 |
| Q1 2014 | -276,426 | Reduce 39.12% | 430,134 | $12.36 |
| Q2 2014 | +1.12 M | Add 261.38% | 1.55 M | $14.31 |
| Q3 2014 | +83,526 | Add 5.37% | 1.64 M | $17.02 |
| Q4 2014 | -150,708 | Reduce 9.20% | 1.49 M | $21.23 |
| Q1 2015 | -38,454 | Reduce 2.59% | 1.45 M | $23.74 |
| Q2 2015 | -783,318 | Reduce 54.07% | 665,484 | $23.74 |
| Q3 2015 | -618,822 | Reduce 92.99% | 46,662 | $23.70 |
| Q4 2015 | -46,662 | Sold Out | 46,662 | $0.00 |
| Q2 2016 | +17,511 | New Buy | 17,511 | $33.24 |
| Q3 2016 | -17,511 | Sold Out | 17,511 | $0.00 |
| Q3 2017 | +23,808 | New Buy | 23,808 | $36.42 |
| Q4 2017 | +88,815 | Add 373.05% | 112,623 | $37.57 |
| Q1 2018 | -112,623 | Sold Out | 112,623 | $0.00 |
| Q4 2019 | +89,811 | New Buy | 89,811 | $77.76 |
| Q1 2020 | -89,811 | Sold Out | 89,811 | $0.00 |
| Q2 2020 | +16,482 | New Buy | 16,482 | $69.11 |
| Q3 2020 | -16,482 | Sold Out | 16,482 | $0.00 |
| Q3 2021 | +10,246 | New Buy | 10,246 | $113.21 |
| Q4 2021 | -4,593 | Reduce 44.83% | 5,653 | $129.49 |
| Q1 2022 | +13,398 | Add 237.01% | 19,051 | $117.74 |
| Q2 2022 | -12,995 | Reduce 68.21% | 6,056 | $95.11 |
| Q3 2022 | +20,684 | Add 341.55% | 26,740 | $82.65 |
| Q4 2022 | +24,513 | Add 91.67% | 51,253 | $74.61 |
| Q1 2023 | -4,731 | Reduce 9.23% | 46,522 | $82.73 |
| Q2 2023 | -24,129 | Reduce 51.87% | 22,393 | $94.33 |
| Q3 2023 | -10,835 | Reduce 48.39% | 11,558 | $69.28 |
| Q4 2023 | +6,738 | Add 58.30% | 18,296 | $76.25 |
| Q1 2024 | -6,468 | Reduce 35.35% | 11,828 | $95.56 |
| Q2 2024 | +30 | Add 0.25% | 11,858 | $92.37 |
| Q3 2024 | -3,879 | Reduce 32.71% | 7,979 | $65.99 |
| Q4 2024 | +8,444 | Add 105.83% | 16,423 | $74.03 |
| Q1 2025 | +27,237 | Add 165.85% | 43,660 | $72.48 |
| Q2 2025 | -365 | Reduce 0.84% | 43,295 | $78.21 |
| Q3 2025 | -9,839 | Reduce 22.73% | 33,456 | $77.77 |
Joel Greenblatt's Edwards Lifesciences Corporation Investment FAQs
Joel Greenblatt first purchased Edwards Lifesciences Corporation (EW) in Q2 2013, acquiring 252,732 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt has held Edwards Lifesciences Corporation (EW) for 50 quarters since Q2 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's largest addition to Edwards Lifesciences Corporation (EW) was in Q2 2014, adding 1,554,438 shares worth $22.24 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 33,456 shares of Edwards Lifesciences Corporation (EW), valued at approximately $2.6 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Edwards Lifesciences Corporation (EW) represents approximately 0.01% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Joel Greenblatt's peak holding in Edwards Lifesciences Corporation (EW) was 1,637,964 shares, as reported at the end of Q3 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.